From Cancer to Cure

The global scientific research community continues to forge better tools with which to diagnose, treat, and prevent cancer.

Published February 01, 2013

From Cancer to Cure

Cancer is the world's leading cause of death, followed by heart disease and stroke. There are over 100 known types of cancer affecting the worldwide population. The global scientific research community continues to endeavor to find better ways to diagnose, treat, and prevent these cancers, with the ultimate goal to one day find a cure.

The Academy's scientific teams convene research experts from around the world, often across scientific disciplines, in order to share ideas and collaborate on the latest research findings. Below are some of the upcoming Academy-sponsored conferences and latest publications on cancer research. Topics span environmental contaminants as they relate to cancer, the use of nanotechnology for cancer diagnostics and treatments, the latest in Pancreatic cancer research, as well as how factors such as obesity are contributing to the global cancer epidemic.

The Bone Marrow Niche, Stem Cells, and Leukemia: Impact of Drugs, Chemicals, and the Environment
Conference

The Bone Marrow Niche, Stem Cells, and Leukemia: Impact of Drugs, Chemicals, and the Environment

May 29–31, 2013 (New York City, USA)
Over 20,000 Americans are diagnosed each year with bone marrow failure syndromes. This conference will bring together experts from toxicology research and hematology research in order to better understand, prevent, and treat myeloid neoplasms.

Nanotechnologies in Cancer Diagnosis, Therapy, and Prevention
Conference

Nanotechnologies in Cancer Diagnosis, Therapy, and Prevention

June 11–13, 2013 (Moscow, Russia)
Featuring a keynote address by Nobel Laureate Robert Y. Tsien, PhD, this 2.5-day conference in Moscow, Russia, will discuss: nanodiagnostics for cancer biomarkers and imaging; nanoparticle toxicity and safety; nanovaccines and nanoimmunotherapeutics; the challenges of targeted delivery in tumors; and nanoparticle-based gene therapy.

Pancreatic Cancer: Translation of New Ideas
eBriefing

Pancreatic Cancer: Translation of New Ideas

Pancreatic cancer is a leading cause of cancer death in the USA and is poised to become even more significant in coming decades. This cancer usually goes undetected until it has reached advanced stages, and patients face dismal prognoses due to the lack of effective therapies. Expert scientists, translational researchers, and clinical investigators explore multiple promising new approaches to treating this deadly disease.

Toward Personalized Medicine for Cancer
Annals

Toward Personalized Medicine for Cancer

Advances in medical genetics and human genetics have enabled a more detailed understanding of the impact of genetics in cancer. This volume explores cancer as an individualized problem and addresses the impact of recent advances in cancer biology, genetics, tumor profiling, and medical technology in the personalization of cancer predisposition, diagnosis, prognosis, treatment, and therapy development.

Cancer Vaccines and Cancer Immunotherapy & Immunomodulation
eBriefing

Cancer Vaccines and Cancer Immunotherapy & Immunomodulation

Explore the second generation of emerging therapies and vaccines, as researchers from academia and the biomedical industry discuss new advances in cancer immunology, vaccine development, and recent clinical trials applying different immunomodulatory strategies.

Cancer Metabolomics: Elucidating the Biochemical Programs that Support Cancer Initiation and Progression
eBriefing

Cancer Metabolomics: Elucidating the Biochemical Programs that Support Cancer Initiation and Progression

The Warburg effect, named after German biochemist, Otto Warburg, defined the field of cancer metabolomics. Otto observed that tumor tissues and normal tissues metabolize glucose differently. These metabolic differences could drive the formation of new cancers or could speed their growth. Explore this eBriefing for the latest in cancer metabolomics research.

Unraveling the Obesity-Cancer Connection
Podcast

Unraveling the Obesity–Cancer Connection

You've heard it once; you've heard it a thousand times: the U.S. has a big problem with obesity. But did you know that there are demonstrated links between obesity and all kinds of serious health problems—including cancer? Explore the obesity–cancer connection through this Academy-sponsored podcast.


About the New York Academy of Sciences
The New York Academy of Sciences is an independent, not-for-profit organization that since 1817 has been committed to advancing science, technology, and society worldwide. With 25,000 members in 140 countries, the Academy is creating a global community of science for the benefit of humanity. The Academy's core mission is to advance scientific knowledge, positively impact the major global challenges of society with science-based solutions, and increase the number of scientifically informed individuals in society at large. Please visit us online at www.nyas.org.